Phase 3 SELVA study evaluating QTORIN™ rapamycin 3.9% anhydrous gel (QTORIN™ rapamycin) for microcystic lymphatic ...
Phase 1 Colorectal Cancer expansion data on track for Q1 2026 - - Varsetatug masetecan (“Varseta-M”) Phase 1 combination study with bevacizumab in Colorectal Cancer to start in Q1 2026 with initial da ...
Abstract: The integration of unmanned aerial vehicles (UAVs) and marine communication networks has been emerging as a promising paradigm to cater for the growing maritime activities, e.g., marine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback